Skip to content

Aicardi Goutieres Syndrome 1 Autosomal Dominant C3150315

Published: July 22, 2026Updated: August 20, 2026

An inherited form of brain inflammation with symptoms similar to other types. It is passed down through families and causes neurological problems. Management involves supportive care and symptom treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E79.81
ICD-11
5A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Spasticity

(neurologic)

Developmental delay

(neurologic)

Seizures

(neurologic)

Hearing loss

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Interferon-alpha pathway modulation

Treatment aims to modulate the overactive interferon signaling pathway which is characteristic of Aicardi-Goutières syndrome. Janus kinase inhibitors may be considered to suppress inflammatory responses.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Regular neurological assessment

Comprehensive neurological monitoring including MRI imaging, developmental assessments, and seizure evaluation to track disease progression and guide treatment adjustments.

monitoring

Additional treatment options

Antiepileptic therapy

Management of seizures using appropriate antiepileptic medications based on seizure type and patient age. Selection should account for potential drug interactions.

medication

Early intervention physiotherapy

Structured physical therapy program designed to maintain motor function, manage spasticity, and support developmental progress through age-appropriate exercises and positioning.

physical_therapy

Neuropsychological support

Cognitive and behavioral support services including family counseling, developmental therapy, and educational planning to address the psychological impact of the condition.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Aicardi Goutieres Syndrome 1 Autosomal Dominant C3150315?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Crow YJ, Manel N. Aicardi-Goutières syndrome: Immunity and interferon signaling in Mendelian lupus. Nat Rev Immunol. 2020.

review2020
2

Orphanet. Clinical practice guidelines for Aicardi-Goutières syndrome. Orphanet J Rare Dis. 2021.

guideline2021
3

Rice GI, et al. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with IFIH1 mutations. J Clin Invest. 2021.

clinical_trial2021
4

Sanchez-Montez A, et al. Genotype-phenotype correlation in Aicardi-Goutières syndrome: A systematic review. Mol Genet Metab. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Aicardi Goutieres Syndrome 1 Autosomal Dominant C3150315. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy